CANADIAN SOLAR INC (CSIQ) Stock Fundamental Analysis

NASDAQ:CSIQ • CA1366351098

17.71 USD
-2.23 (-11.18%)
At close: Feb 27, 2026
17.8 USD
+0.09 (+0.51%)
After Hours: 2/27/2026, 8:00:00 PM
Fundamental Rating

2

Overall CSIQ gets a fundamental rating of 2 out of 10. We evaluated CSIQ against 114 industry peers in the Semiconductors & Semiconductor Equipment industry. CSIQ has a bad profitability rating. Also its financial health evaluation is rather negative. CSIQ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • CSIQ had negative earnings in the past year.
  • CSIQ had a negative operating cash flow in the past year.
  • Each year in the past 5 years CSIQ has been profitable.
  • The reported operating cash flow has been mixed in the past 5 years: CSIQ reported negative operating cash flow in multiple years.
CSIQ Yearly Net Income VS EBIT VS OCF VS FCFCSIQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B

1.2 Ratios

  • With a Return On Assets value of 0.11%, CSIQ perfoms like the industry average, outperforming 49.12% of the companies in the same industry.
  • CSIQ has a Return On Equity (0.56%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.11%
ROE 0.56%
ROIC N/A
ROA(3y)1.74%
ROA(5y)1.75%
ROE(3y)8.12%
ROE(5y)7.8%
ROIC(3y)N/A
ROIC(5y)N/A
CSIQ Yearly ROA, ROE, ROICCSIQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • CSIQ's Profit Margin of 0.27% is in line compared to the rest of the industry. CSIQ outperforms 49.12% of its industry peers.
  • In the last couple of years the Profit Margin of CSIQ has declined.
  • The Gross Margin of CSIQ (18.97%) is worse than 80.70% of its industry peers.
  • In the last couple of years the Gross Margin of CSIQ has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 0.27%
GM 18.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-30.67%
PM growth 5Y-35.43%
GM growth 3Y-1.09%
GM growth 5Y-5.77%
CSIQ Yearly Profit, Operating, Gross MarginsCSIQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

0

2. Health

2.1 Basic Checks

  • CSIQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CSIQ has more shares outstanding than it did 1 year ago.
  • CSIQ has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CSIQ is higher compared to a year ago.
CSIQ Yearly Shares OutstandingCSIQ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CSIQ Yearly Total Debt VS Total AssetsCSIQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • Based on the Altman-Z score of 0.63, we must say that CSIQ is in the distress zone and has some risk of bankruptcy.
  • CSIQ has a Altman-Z score of 0.63. This is in the lower half of the industry: CSIQ underperforms 70.18% of its industry peers.
  • CSIQ has a Debt/Equity ratio of 1.60. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.60, CSIQ is doing worse than 90.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF N/A
Altman-Z 0.63
ROIC/WACCN/A
WACC4.57%
CSIQ Yearly LT Debt VS Equity VS FCFCSIQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B 3B

2.3 Liquidity

  • CSIQ has a Current Ratio of 1.07. This is a normal value and indicates that CSIQ is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.07, CSIQ is doing worse than 90.35% of the companies in the same industry.
  • CSIQ has a Quick Ratio of 1.07. This is a bad value and indicates that CSIQ is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.86, CSIQ is doing worse than 89.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 0.86
CSIQ Yearly Current Assets VS Current LiabilitesCSIQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

  • The earnings per share for CSIQ have decreased strongly by -27000.00% in the last year.
  • CSIQ shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -28.29% yearly.
  • CSIQ shows a decrease in Revenue. In the last year, the revenue decreased by -4.46%.
  • Measured over the past years, CSIQ shows a quite strong growth in Revenue. The Revenue has been growing by 13.37% on average per year.
EPS 1Y (TTM)-27000%
EPS 3Y-26.92%
EPS 5Y-28.29%
EPS Q2Q%66.67%
Revenue 1Y (TTM)-4.46%
Revenue growth 3Y4.33%
Revenue growth 5Y13.37%
Sales Q2Q%-1.34%

3.2 Future

  • Based on estimates for the next years, CSIQ will show a very strong growth in Earnings Per Share. The EPS will grow by 52.21% on average per year.
  • Based on estimates for the next years, CSIQ will show a small growth in Revenue. The Revenue will grow by 7.23% on average per year.
EPS Next Y15.17%
EPS Next 2Y59.35%
EPS Next 3Y43.71%
EPS Next 5Y52.21%
Revenue Next Year-6.68%
Revenue Next 2Y10.16%
Revenue Next 3Y11.22%
Revenue Next 5Y7.23%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CSIQ Yearly Revenue VS EstimatesCSIQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
CSIQ Yearly EPS VS EstimatesCSIQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CSIQ. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 22.81, the valuation of CSIQ can be described as rather expensive.
  • 78.95% of the companies in the same industry are more expensive than CSIQ, based on the Price/Forward Earnings ratio.
  • CSIQ's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.06.
Industry RankSector Rank
PE N/A
Fwd PE 22.81
CSIQ Price Earnings VS Forward Price EarningsCSIQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

  • 90.35% of the companies in the same industry are more expensive than CSIQ, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.9
CSIQ Per share dataCSIQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CSIQ's earnings are expected to grow with 43.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.35%
EPS Next 3Y43.71%

0

5. Dividend

5.1 Amount

  • No dividends for CSIQ!.
Industry RankSector Rank
Dividend Yield 0%

CANADIAN SOLAR INC

NASDAQ:CSIQ (2/27/2026, 8:00:00 PM)

After market: 17.8 +0.09 (+0.51%)

17.71

-2.23 (-11.18%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-13
Earnings (Next)03-12
Inst Owners40.01%
Inst Owner Change5.53%
Ins Owners21.18%
Ins Owner ChangeN/A
Market Cap1.19B
Revenue(TTM)5.90B
Net Income(TTM)16.11M
Analysts51.76
Price Target21.53 (21.57%)
Short Float %27.14%
Short Ratio3.65
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.47%
Min EPS beat(2)-104.86%
Max EPS beat(2)85.92%
EPS beat(4)2
Avg EPS beat(4)-350.99%
Min EPS beat(4)-1389.64%
Max EPS beat(4)85.92%
EPS beat(8)3
Avg EPS beat(8)-35.82%
EPS beat(12)6
Avg EPS beat(12)-13.19%
EPS beat(16)9
Avg EPS beat(16)13.65%
Revenue beat(2)1
Avg Revenue beat(2)-4.03%
Min Revenue beat(2)-14.75%
Max Revenue beat(2)6.7%
Revenue beat(4)2
Avg Revenue beat(4)-1.53%
Min Revenue beat(4)-14.75%
Max Revenue beat(4)7.03%
Revenue beat(8)4
Avg Revenue beat(8)-2.31%
Revenue beat(12)5
Avg Revenue beat(12)-3.16%
Revenue beat(16)6
Avg Revenue beat(16)-3.56%
PT rev (1m)0%
PT rev (3m)31.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-244.25%
EPS NY rev (1m)4.05%
EPS NY rev (3m)-25.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-14.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 22.81
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 0.41
P/tB 0.42
EV/EBITDA 11.9
EPS(TTM)-2.69
EYN/A
EPS(NY)0.78
Fwd EY4.38%
FCF(TTM)-25.95
FCFYN/A
OCF(TTM)-1.81
OCFYN/A
SpS88.09
BVpS42.83
TBVpS42.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.11%
ROE 0.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.27%
GM 18.97%
FCFM N/A
ROA(3y)1.74%
ROA(5y)1.75%
ROE(3y)8.12%
ROE(5y)7.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-30.67%
PM growth 5Y-35.43%
GM growth 3Y-1.09%
GM growth 5Y-5.77%
F-Score5
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF N/A
Debt/EBITDA 9.55
Cap/Depr 322.43%
Cap/Sales 27.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 0.86
Altman-Z 0.63
F-Score5
WACC4.57%
ROIC/WACCN/A
Cap/Depr(3y)379.19%
Cap/Depr(5y)289.93%
Cap/Sales(3y)19.88%
Cap/Sales(5y)15.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27000%
EPS 3Y-26.92%
EPS 5Y-28.29%
EPS Q2Q%66.67%
EPS Next Y15.17%
EPS Next 2Y59.35%
EPS Next 3Y43.71%
EPS Next 5Y52.21%
Revenue 1Y (TTM)-4.46%
Revenue growth 3Y4.33%
Revenue growth 5Y13.37%
Sales Q2Q%-1.34%
Revenue Next Year-6.68%
Revenue Next 2Y10.16%
Revenue Next 3Y11.22%
Revenue Next 5Y7.23%
EBIT growth 1Y-120.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year446.08%
EBIT Next 3Y105.88%
EBIT Next 5Y64.05%
FCF growth 1Y-227.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-229.32%
OCF growth 3YN/A
OCF growth 5YN/A

CANADIAN SOLAR INC / CSIQ FAQ

Can you provide the ChartMill fundamental rating for CANADIAN SOLAR INC?

ChartMill assigns a fundamental rating of 2 / 10 to CSIQ.


What is the valuation status of CANADIAN SOLAR INC (CSIQ) stock?

ChartMill assigns a valuation rating of 3 / 10 to CANADIAN SOLAR INC (CSIQ). This can be considered as Overvalued.


What is the profitability of CSIQ stock?

CANADIAN SOLAR INC (CSIQ) has a profitability rating of 2 / 10.


How financially healthy is CANADIAN SOLAR INC?

The financial health rating of CANADIAN SOLAR INC (CSIQ) is 0 / 10.